CTOs on the Move

Very Good Food

www.verygoodfood.com

 
We are an emerging plant-based food technology company that designs, develops, produces, distributes and sells a variety of plant-based meat and other food alternatives. Our mission is to employ plant-based food technology to create products that are delicious while maintaining a wholesome nutritional profile.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Riceland Foods, Inc.

Riceland Foods, Inc. is one of the leading companies in the Manufacturing sector.

Atlantic Sapphire

Atlantic Sapphire produces Bluehouse raised salmon that is made in the USA, delicious, healthy, eco-friendly and all natural. Read more about our product.

Vessel Packaging

Vessel offers everything from mobile canning and design services to printed cans and pressure sensitive labeling to our customers We`ve grown into a one stop shop, which means we`re doing everything from prepping the canning line at dawn to running the labeling lines at dusk. We are owned and run completely independently by four friends, our founders. Since the beginning, they`ve been hands-on with every part of the business. There`s now a big team of us spread across the country that keeps the cogs turning and the beverages flowing.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.